Abstract
γ-Folic acid conjugates are valuable tools for targeting the folate receptor, an important cancer biomarker, but direct conjugation of folic acid is hampered by poor regioselectivity and challenging purification. We report an orthogonal protection strategy that enables controlled, regioselective access to γ-folic acid conjugates from readily available building blocks. This approach permits site-selective installation of a range of functional modalities including an amphiphilic ligand, fluorescent probe, and bioorthogonal handle, followed by global deprotection to afford γ-conjugates without the need for reversed phase chromatography.
| Original language | English |
|---|---|
| Number of pages | 6 |
| Journal | Organic Letters |
| Early online date | 27 Nov 2025 |
| DOIs | |
| Publication status | E-pub ahead of print - 27 Nov 2025 |
Funding
The authors thank the University of Strathclyde for Chancellor’s Fellowship funding and Ph.D. studentship funding
Keywords
- folic acid
- cancer biomarkers
- folate receptor